Filing Details
- Accession Number:
- 0001209191-21-067938
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-03 17:37:31
- Reporting Period:
- 2021-12-01
- Accepted Time:
- 2021-12-03 17:37:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1598646 | Minerva Neurosciences Inc. | NERV | Pharmaceutical Preparations (2834) | 260784194 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1642053 | David Kupfer | C/O Minerva Neurosciences, Inc., 1601 Trapelo Road, Suite 286 Waltham MA 02451 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-12-01 | 55,635 | $0.88 | 163,553 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 27,935 | Indirect | By wife |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.85 to $0.9235 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.